Rubia, Ernalyn M.
HRN: 01-17-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/04/2024
03/10/2024
IVTT
1.5 G
Q6
Cap MR (T/c Aspiration Pneumonia
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes